Shuttle Pharmaceuticals Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Shuttle Pharmaceuticals Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
  • Shuttle Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.78M, a 111% decline year-over-year.
  • Shuttle Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.19M, a 19.8% decline year-over-year.
  • Shuttle Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.59M, a 32% decline from 2022.
  • Shuttle Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5M, a 334% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$9.19M -$3.78M -$1.99M -111% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$7.2M -$2.03M +$153K +7.01% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$7.35M -$1.73M -$756K -77.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$6.59M -$1.64M +$1.08M +39.7% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-09-04
Q3 2023 -$7.67M -$1.79M -$794K -79.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$6.88M -$2.18M -$1.59M -266% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$5.29M -$975K -$293K -43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$5M -$2.72M -$2.26M -492% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-09-04
Q3 2022 -$2.74M -$998K -$781K -360% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.96M -$597K -$250K -72.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$1.7M -$682K -$553K -427% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$1.15M -$459K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$217K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$347K Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$129K Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.